CASTLE ROCK, CO, July 8 / MARKET WIRE/ -- AspenBio Pharma, Inc. (NASDAQ: APPY), an emerging bio-pharmaceutical company dedicated to the development of novel drugs and diagnostics for humans and animals, has appointed Michael R. Merson as a new independent member of its board of directors. This appointment brings the total number of company directors to seven, with five serving independently. Merson is a highly seasoned health care executive, having founded and managed several healthcare organizations, from hospitals to health insurers. Since 2004, he has served as chairman of CareFirst Blue Cross/Blue Shield, the 16th largest health insurer in the United States, with annual revenues of approximately $7.0 billion and more than 3.2 million insured individuals. CareFirst is part of the BlueCross/Blue Shield group of insurance...
[read full story]
Your Web Site
